|
LGR4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.23234755733392E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66755498298699E-12 |
| Normal-vs-Stage2 |
1.97880001273631E-09 |
| Normal-vs-Stage3 |
4.62329999950661E-07 |
| Normal-vs-Stage4 |
1.089770E-01 |
| Stage1-vs-Stage2 |
9.676400E-01 |
| Stage1-vs-Stage3 |
7.876800E-01 |
| Stage1-vs-Stage4 |
6.309200E-01 |
| Stage2-vs-Stage3 |
7.780000E-01 |
| Stage2-vs-Stage4 |
6.280600E-01 |
| Stage3-vs-Stage4 |
7.193600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64634972321664E-12 |
| Normal-vs-AfricanAmerican |
1.83675297193986E-12 |
| Normal-vs-Asian |
3.64539999997415E-06 |
| Caucasian-vs-AfricanAmerican |
7.901000E-01 |
| Caucasian-vs-Asian |
7.712400E-01 |
| AfricanAmerican-vs-Asian |
7.494000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6251444634463E-12 |
| Normal-vs-Female |
4.30879999999689E-05 |
| Male-vs-Female |
1.776350E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.5289999999446E-07 |
| Normal-vs-Extreme_Weight |
1.5807355424613E-12 |
| Normal-vs-Obese |
1.28289601164511E-11 |
| Normal-vs-Extreme_Obese |
4.83410000917672E-09 |
| Normal_Weight-vs-Extreme_Weight |
6.645200E-01 |
| Normal_Weight-vs-Obese |
8.288200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.614400E-01 |
| Extreme_Weight-vs-Obese |
4.046600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.318600E-01 |
| Obese-vs-Extreme_Obese |
3.170600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.298290E-03 |
| Normal-vs-Age(41-60Yrs) |
1.03499997461398E-09 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
2.85150014711633E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.129800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.475900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.411800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.999790E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.790400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.051600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62703184258817E-12 |
| Normal-VS-Type2 PRCC |
1.64079860809352E-12 |
| Normal-VS-KIRP CIMP |
7.300400E-01 |
| Normal-VS-Unclassified PRCC |
1.00699999450171E-08 |
| Type1 PRCC-VS-Type2 PRCC |
7.777200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.090180E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.907800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.007610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.630800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.441760E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.992710E-04 |
| Normal-vs-N2 |
8.098800E-01 |
| N0-vs-N1 |
4.055600E-02 |
| N0-vs-N2 |
5.439000E-01 |
| N1-vs-N2 |
7.400800E-01 |
|
|
